Indefinite Delivery Contract SPE2DX15D9253

The Defense Logistics Agency (DLA) awarded an indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, under the DLA's SPE2DB program, allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

The IDC has an ultimate completion date of December 31, 2025. Under this contract, DMS Pharmaceutical Group has received multiple delivery orders for specific pharmaceutical products such as injections, tablets, creams, auto-injectors, and specialty medications, with award values ranging from a few dollars to over $4,000. These delivery orders do not have any set-aside designations. DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of critical pharmaceutical and medical supplies to the Department of Defense through this IDC and other prime vendor contracts.